📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

Vietnam develops 'world's first' African swine fever vaccine for commercial use

Published 06/01/2022, 06:57 AM
Updated 06/01/2022, 07:02 AM
© Reuters. FILE PHOTO: Pigs are seen at a farm outside Hanoi, Vietnam June 28, 2019. Picture taken June 28, 2019. REUTERS/Kham

HANOI (Reuters) - Vietnam said on Wednesday it had successfully developed a vaccine to administer to pigs to fight African swine fever, with the aim of becoming the first country to commercially produce and export it.

African swine fever, one of the most devastating livestock diseases, was first detected in Vietnam in February 2019 and forced the country to cull around 20% of its hog herd last year.

It originated in Africa before spreading to Europe and Asia and has killed hundreds of millions of pigs globally. African swine fever is harmless to humans.

"This is a milestone of the veterinary industry," deputy agriculture minister Phung Duc Tien said in a statement.

"With immunity lasting six months, the vaccine will be a shield for hog-raising industry and pig production globally."

The vaccine has been in development since November 2019 in partnership with United States experts, with five clinical trials held.

Its safety and efficacy was confirmed by the Agricultural Research Service under the U.S. Department of Agriculture, Tien said.

"This success opens great expectations and the room to export African swine fever vaccine produced in Vietnam is huge," Tien added.

© Reuters. FILE PHOTO: Pigs are seen at a farm outside Hanoi, Vietnam June 28, 2019. Picture taken June 28, 2019. REUTERS/Kham

He did not provide a timeframe for when the vaccine could be exported or estimate of Vietnam's production capacity.

Although the swine fever outbreak has subsided in Vietnam, allowing farmers to rebuild hog herds, the virus is still hurting farms in some countries.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.